Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: A population-based study

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 8, 2012, Pages 772-781

  Gerber, L ^a,b,c   Otgonsuren, M ^a   Mishra, A ^a   Escheik, C ^a   Birerdinc, A ^a   Stepanova, M ^a   Younossi, Z M ^a,b  

^a INOVA FAIRFAX HOSPITAL   (United States)

^b BETTY AND GUY BEATTY CENTER FOR INTEGRATED RESEARCH   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; GLUCOSE; INSULIN;

ACCELEROMETRY; ADULT; ARTHRITIS; ARTICLE; BODY MASS; COMORBIDITY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DYSLIPIDEMIA; ETHNICITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; PHYSICAL ACTIVITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; SEDENTARY LIFESTYLE; SKINFOLD THICKNESS; STROKE; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADULT; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EXERCISE; FATTY LIVER; FEMALE; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEDENTARY LIFESTYLE; WAIST CIRCUMFERENCE;

EID: 84866407037     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12038     Document Type: Article

References (33)

1. Dunn W, Xu R, Wingard DL, et al,. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008; 103: 2263-71.
2. Pi-Sunyer FX,. The obesity epidemic: pathophysiology and consequences of obesity. Obes Res 2002; 10 (Suppl. 2): 97S-104S.
3. Ford ES, Giles WH, Dietz WH,. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356-9.
4. Mokdad AH, Ford ES, Bowman BA, et al,. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 76-9.
5. McMillan KP, Kuk JL, Church TS, Blair SN, Ross R,. Independent associations between liver fat, visceral adipose tissue, and metabolic risk factors in men. Appl Physiol Nutr Metab 2007; 32: 265-72.
6. Younossi ZM, Gramlich T, Matteoni CA, Boparai N, McCullough AJ,. Nonalcoholic fatty liver disease in patients with type 2 diabetes. Clin Gastroenterol Hepatol 2004; 2: 262-5.
7. Cortez-Pinto H, Camilo ME, Baptista A, De Oliveira AG, De Moura MC,. Non-alcoholic fatty liver: another feature of the metabolic syndrome? Clin Nutr 1999; 18: 353-8.
8. Marchesini G, Brizi M, Bianchi G, et al,. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001; 50: 1844-50.
9. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ,. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116: 1413-9.
10. Targher G, Bertolini L, Padovani R, et al,. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30: 1212-8.
11. Targher G, Arcaro G,. Non-alcoholic fatty liver disease and increased risk of cardiovascular disease. Atherosclerosis 2007; 191: 235-40.
12. Church TS, Kuk JL, Ross R, Priest EL, Biltoft E, Blair SN,. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 2006; 130: 2023-30.
13. Rector RS, Thyfault JP, Wei Y, Ibdah JA,. Non-alcoholic fatty liver disease and the metabolic syndrome: an update. World J Gastroenterol 2008; 14: 185-92.
14. Veldt BJ, Chen W, Heathcote EJ, et al,. Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus. Hepatology 2008; 47: 1856-62.
15. Angulo P,. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221-31.
16. Krasnoff JB, Painter PL, Wallace JP, Bass NM, Merriman RB,. Health-related fitness and physical activity in patients with nonalcoholic fatty liver disease. Hepatology 2008; 47: 1158-66.
17. Thoma C, Day CP, Trenell MI,. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol 2012; 56: 255-66.
18. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN,. Cardiorespiratory fitness attenuates metabolic-associated mortaliy risk in normal weight, overweight, and obese men. Med Sci Sports Exerc 2004; 36: S135.
19. Williams PT,. Attenuating the effect of vigorous physical in risk for inherited obesity: a study of 47,691 runners. PLoS ONE 2012; 7: e31436.
20. Hansen D, Dendale P, van Loon LJ, Meeusen R,. The impact of training modalities on the clinical benefits of exercise intervention in patients with cardiovascular disease risk or type 2 diabetes mellitus. Sports Med 2010; 40: 921-40.
21. CDC/National Center for Health Statistics. National Health and Nutrition Examination Survey: Analytic Guidelines [Internet]. Hyattsville (MD): US Department of Health and Human Services, Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/nchs/data/nhanes/nhanes-03-04/ nhanes-analytic-guidelines-dec-2005.pdf. Accessed June 18, 2009.
22. Bedogni G, Bellentani S, Miglioli L, et al,. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-9.
24. GJ Welk,. Physical Activity Assessments for Health-Related Research. Champaign, Illinois: Human Kinetics, 2002.
25. Troiano RP, Berrigan D, Dodd KW, Masse LC, Tilert T, McDowell M,. Physical activity in the United States measured by accelerometer. Med Sci Sports Exerc 2008; 40: 181-8.
26. Kistler KD, Brunt EM, Clark M, Diehl AM, Sallis JF, Schurmmer B,; NASH CRN Research Gr. Physical activity recommendations, exercise intensity and histopathology severity of NAFLD. Am J Gastroenterol 2011; 106: 460-8.
27. Johnson NA, Geroge J,. Fitness versus Fatness;Moving Beyond Weight Loss in NAFLD. Hepatology 2010; 52: 370-81.
28. Sallis JF, Saelens BF,. Assessment of physical activity by self-report, status, limitation and future direction. Res Q Exerc Sport 2000; 71: S1-16.
29. Kantartzisk K, Thamer C, Peter A, Machann J, Schick F, Schram C,. High cardio-respiratory fitness is an independent predictor of the reduction in liver fat during lifestyle intervention in NAFLD. Gut 2009; 58: 1281-8.
30. Fabbrini E, Sullivan S, Klein S,. Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 2010; 51: 679-89.
31. Deivanayagam S, Mohammed BS, Vitola BE, et al,. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am J Clin Nutr 2008; 88: 257-62.
32. Bedogni G, Bellentani S, Miglioli L, et al,. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 2006; 6: 33.
33. Calori G, Lattuada G, Ragogna F, et al,. Fatty liver index and mortality: the Cremona study in the 15th year of follow-up. Hepatology 2011; 54: 145-52.